drugset / Trial / NCT07086924

Genetic Variation in TRAF3IP2 (rs13190932)

NCT07086924

Recruiting 50 enrolled South Valley University
RandomizedParallel-groupOpen-labelTreatment

Summary

Psoriasis is an immune-mediated inflammatory disease that is highly prevalent worldwide, affecting approximately 2-3% of the world population. It is characterized by red, scaly plaques that can appear on various parts of the body, causing significant physical and psychological burden to affected individuals. The Pathogenesis of PsA involves a complex interplay of genetic, immunological, and environmental factors.Genetic studies have identified several susceptibility loci, including HLA-Cw6 and IL23R, which are shared with psoriasis. Additionally, the presence of certain alleles, such as HLA-B27, is associated with a more severe disease course and a higher likelihood of axial involvement.

Timeline

Start
2025-06-01
Primary completion
2026-06-01
Completion
2026-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule